The availability of a tumor sample (CRC) from this patient made it possible to test the hypothesis that MSH2-deficiency resulted from two somatic mutations (“Lynch-like syndrome” [14]). The gene discussed is MSH2; the disease is hyperinsulinemic hypoglycemia, familial, 4.